Prescribing for polymyalgia rheumatica. - Wikidata - awgldk - TriplyDB

Prescribing for polymyalgia rheumatica.

Prescribing for polymyalgia rheumatica.

http://www.wikidata.org/entity/Q55205628

about

Prescribing for polymyalgia rheumatica.

http://www.wikidata.org/entity/Q55205628

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Prescribing for polymyalgia rheumatica.

@en

Prescribing for polymyalgia rheumatica.

@nl

type

label

Prescribing for polymyalgia rheumatica.

@en

Prescribing for polymyalgia rheumatica.

@nl

prefLabel

Prescribing for polymyalgia rheumatica.

@en

Prescribing for polymyalgia rheumatica.

@nl

P1433

Q55205628-20B9F1CD-C1A3-4C44-A618-F06AAC2AB5DD

P1476

Q55205628-6E8AADAF-B2B5-4A92-AFFB-5F00FF018FDE

P2093

Q55205628-51749611-82CC-4F8C-9312-9AF0311026D0

P2860

Q55205628-083192B6-80C1-44C1-AEAE-FBF69A8CA7EB

Q55205628-162C9AB6-884F-4A74-BBF8-3DE2AAAF4040

Q55205628-2BD6666D-E4C8-48BA-9B5F-6B6F0329792B

Q55205628-2C22F5CF-25F9-40A0-9008-E37AF480D4CB

Q55205628-449B3FE2-576A-4A2A-97B5-693D10143ED2

Q55205628-487C0063-5366-4BE3-92EC-C65CABEBF963

Q55205628-53C2C771-153E-49B8-9021-2D5C72F5087D

Q55205628-5711A6FA-38D1-4AF0-8472-E53625E23FB1

Q55205628-5E7135BC-120A-45B1-8152-B35399984BB0

Q55205628-6A80944B-89CD-4B6D-B19D-8C1876C9C5AC

P304

Q55205628-26D77E2B-9BCF-4B70-83F6-62BCD9528B0B

P31

Q55205628-F35DF839-604A-42EF-8D2C-1A67B962390B

P356

Q55205628-9B580F2E-95B1-47C4-826D-B6D83CFE60EF

P433

Q55205628-078DBE94-0C8A-4ADF-832F-26172C4307A8

P478

Q55205628-76FCF0B8-8D43-4CE4-9244-732B1C3D7811

P50

Q55205628-3EDC99E3-B1D4-46CE-90FE-44BAC75F63BF

Q55205628-D3992789-E90C-45FA-9052-CA7A18C0107E

P577

Q55205628-7906D465-A575-4C53-A64C-24ED40C34ABA

P698

Q55205628-F3E70739-4182-4684-A8DE-AE310420EA57

P932

Q55205628-3039C9C2-C66E-4ED5-918B-32937E739F76

P356

AUSTPRESCR.2018.001

P1433

Australian Prescriber

P1476

Prescribing for polymyalgia rheumatica.

@en

P2093

Russell R Buchanan

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical practice. Giant-cell arteritis and polymyalgia rheumatica

Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.

Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.

Managing the drug treatment of rheumatoid arthritis.

2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.

Glucocorticoid-targeted therapies for the treatment of rheumatoid arthritis.

The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases.

Treatment of polymyalgia rheumatica: a systematic review.

2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.

Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study.

P304

14-19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18773/AUSTPRESCR.2018.001

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29507455

http://www.w3.org/2001/XMLSchema#string

P932

5828929

http://www.w3.org/2001/XMLSchema#string